Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

GENB

Generate Biomedicines Inc

Mar 13 • 04:00PM ET

13.08

-0.20 -1.51 %

Healthcare • Biotechnology • USA • NASD

Held by: ARKG ONEQ

Index	-	P/E	-	EPS (ttm)	-	Insider Own	-	Shs Outstand	50.30M	Perf Week	16.68%
Market Cap	1.67B	Forward P/E	-	EPS next Y	-	Insider Trans	-	Shs Float	-	Perf Month	-
Enterprise Value	-	PEG	-	EPS next Q	-	Inst Own	-	Short Float	-	Perf Quarter	-
Income	-	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	-	Perf Half Y	-
Sales	-	P/B	-	EPS next Y	-	ROA	-	Short Interest	-	Perf YTD	3.40%
Book/sh	-	P/C	-	EPS next 5Y	-	ROE	-	52W High	15.32 -14.62%	Perf Year	-
Cash/sh	-	P/FCF	-	EPS past 3/5Y	- -	ROIC	-	52W Low	11.00 18.91%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	8.30% -	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-	Oper. Margin	-	ATR (14)	1.56	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	-	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	-	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	-	EPS Q/Q	-	SMA20	6.22%	Beta	-	Target Price	-
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	6.22%	Rel Volume	0.46	Prev Close	13.28
Employees	312	LT Debt/Eq	-	Earnings	-	SMA200	6.22%	Avg Volume	1.51M	Price	13.08
IPO	Feb 27, 2026	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	695,240	Change	-1.51%

Generate Biomedicines, Inc. is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company was founded in 2018, and is headquartered in Somerville, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Nally Michael	Chief Executive Officer	Mar 04 '26	Buy	12.00	20,000	240,000	572,707	Mar 06 04:55 PM
Grous Beth	Chief People Officer	Mar 02 '26	Buy	16.00	300	4,800	300	Mar 02 06:05 PM
Silvers Jason	President & CFO	Mar 02 '26	Buy	16.00	2,000	32,000	1,000	Mar 02 05:54 PM
AFEYAN NOUBAR	Director	Mar 02 '26	Buy	16.00	4,687,500	75,000,000	15,264,724	Mar 02 05:52 PM
Mendillo Jane L	Director	Mar 02 '26	Buy	16.00	1,500	24,000	1,500	Mar 02 05:47 PM
AFEYAN NOUBAR	Director	Mar 02 '26	Buy	16.00	4,687,500	75,000,000	15,264,724	Mar 02 05:42 PM

Open in Screener

MRNA

Moderna Inc

Mar 13 • 04:00PM ET

52.56

-0.83 -1.55 %

Healthcare • Biotechnology • USA • NASD

Peers: BNTX NVAX REGN ALNY INCY BMRN SRPT VRTX GILD BIIB

| Held by: VTI VOO VB RSP IVV VBR SPY XBI IBB XLV

Index	S&P 500	P/E	-	EPS (ttm)	-7.26	Insider Own	8.54%	Shs Outstand	394.00M	Perf Week	0.08%
Market Cap	20.76B	Forward P/E	-	EPS next Y	-4.61	Insider Trans	-0.58%	Shs Float	361.21M	Perf Month	29.75%
Enterprise Value	16.26B	PEG	-	EPS next Q	-2.03	Inst Own	75.81%	Short Float	19.44%	Perf Quarter	81.05%
Income	-2.82B	P/S	10.68	EPS this Y	11.28%	Inst Trans	6.86%	Short Ratio	5.90	Perf Half Y	107.01%
Sales	1.94B	P/B	2.39	EPS next Y	28.45%	ROA	-21.31%	Short Interest	70.23M	Perf YTD	78.23%
Book/sh	21.95	P/C	3.58	EPS next 5Y	26.18%	ROE	-28.87%	52W High	59.55 -11.74%	Perf Year	53.24%
Cash/sh	14.69	P/FCF	-	EPS past 3/5Y	- -29.93%	ROIC	-28.47%	52W Low	22.28 135.91%	Perf 3Y	-64.46%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-53.32% 19.33%	Gross Margin	44.29%	Volatility	6.37% 7.45%	Perf 5Y	-61.63%
Dividend TTM	-	EV/Sales	8.37	EPS Y/Y TTM	21.76%	Oper. Margin	-158.13%	ATR (14)	3.92	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.22	Sales Y/Y TTM	-39.93%	Profit Margin	-145.16%	RSI (14)	55.56	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.29	EPS Q/Q	27.57%	SMA20	2.13%	Beta	1.33	Target Price	41.84
Payout	-	Debt/Eq	0.15	Sales Q/Q	-29.81%	SMA50	16.61%	Rel Volume	0.55	Prev Close	53.39
Employees	4700	LT Debt/Eq	0.15	Earnings	Feb 13 BMO	SMA200	65.14%	Avg Volume	11.90M	Price	52.56
IPO	Dec 07, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	17.07% 6.75%	Trades		Volume	6,561,686	Change	-1.55%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-28-26	Resumed	Barclays	Equal Weight	$25
Jan-07-26	Resumed	UBS	Neutral	$34
Dec-12-25	Initiated	Jefferies	Hold	$30
Mar-13-25	Initiated	Citigroup	Neutral	$40
Feb-18-25	Downgrade	Barclays	Overweight → Equal Weight	$111 → $45
Jan-29-25	Downgrade	Goldman	Buy → Neutral	$99 → $51
Dec-18-24	Downgrade	Argus	Buy → Hold
Dec-10-24	Resumed	BofA Securities	Underperform	$41
Nov-19-24	Initiated	Berenberg	Hold	$42
Nov-18-24	Upgrade	HSBC Securities	Hold → Buy	$58
Nov-15-24	Initiated	Wolfe Research	Underperform	$40
Oct-17-24	Initiated	Bernstein	Mkt Perform	$55
Sep-13-24	Downgrade	Oppenheimer	Outperform → Perform
Sep-13-24	Downgrade	JP Morgan	Neutral → Underweight	$88 → $70
Sep-13-24	Downgrade	Jefferies	Buy → Hold	$120 → $65
Aug-28-24	Upgrade	HSBC Securities	Reduce → Hold	$82
Aug-07-24	Upgrade	Deutsche Bank	Sell → Hold	$85 → $80
Aug-05-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$125 → $90
Feb-26-24	Downgrade	HSBC Securities	Hold → Reduce	$75 → $86
Jan-02-24	Upgrade	Oppenheimer	Perform → Outperform	$142

Show Previous Ratings

Mar-13-26 07:54AM	GSKs RSV vaccine wins broader FDA clearance (BioPharma Dive)
Mar-10-26 11:01AM	Kohl's Q4 sales miss, EV maker NIO reports first quarterly profit (Yahoo Finance Video)
09:24AM	BioNTech Reports Earnings. That's Not Why the Stock Is Down 17%. (Barrons.com)
08:40AM	BioNTech Stock Tumbles As Co-Founders Pivot To New MRNA Venture (Benzinga)
08:19AM	BioNTechs Founding Duo Will Leave to Start New mRNA Firm (Bloomberg)
04:37PM	Loading…
Mar-09-26 04:37PM	This biotech's stock soared after a 'polarizing' FDA official is stepping down (MarketWatch) +6.13%
01:32PM	What's Going On With Moderna, Capricor, Other Biotech Stocks On Monday? (Benzinga)
10:11AM	Stocks to Watch Monday: Boeing, Live Nation, Moderna, United Machines (The Wall Street Journal)
07:01AM	Why Is uniQure Stock Skyrocketing Monday? (Benzinga)
Mar-08-26 10:25PM	Corrections & Amplifications (The Wall Street Journal)
Mar-07-26 12:41AM	Controversial FDA Vaccines Chief Vinay Prasad To Leave Agency In April (Benzinga)
Mar-06-26 06:05PM	Moderna Pops As Vinay Prasad, The FDA's Controversial Vaccine Head, Will Depart In April (Investor's Business Daily) +6.13%
08:30AM	These 3 Stocks Just Bounced From Lows What Wall Street Thinks Comes Next (24/7 Wall St.)
Mar-05-26 12:33PM	Moderna pays up to $2.25bn to settle drug delivery tech patent lawsuit (Pharmaceutical Technology) -6.87%
08:41AM	Reddit Traders Are Cheering Moderna While Bears Watch the Cash Burn (24/7 Wall St.)
06:32AM	Loading…
06:32AM	Stocks Slip Before the Open as Bond Yields Climb on Inflation Worries, U.S. Economic Data on Tap (Barchart)
Mar-04-26 08:00PM	Moderna (MRNA) Climbs 16% as Arbutus-Genevant Legal Battle Clears (Insider Monkey) +15.99%
07:55PM	Review & Preview: Stocks Show Resilience (Barrons.com)
05:10PM	Health Care Roundup: Market Talk (The Wall Street Journal)
04:50PM	These Stocks Are Todays Movers: Moderna, Coinbase, Strategy, CoreWeave, Micron, Sandisk, GitLab, and More (Barrons.com)
04:33PM	Stocks Settle Higher as US Economic Resilience Overshadows Iran Conflict (Barchart)
04:32PM	Moderna Stock Shoots Up on $2.3 Billion Patent Settlement (The Wall Street Journal)
04:04PM	Moderna Stock Pops After Inking $950 Million Covid Vaccine Settlement (Investor's Business Daily)
04:00PM	Why Moderna (MRNA) Stock Is Trading Up Today (StockStory)
02:41PM	Analyst Report: Moderna, Inc. (Morningstar Research)
02:35PM	Moderna Settles a Covid Vaccine Patent Lawsuit. What It Means for the Stock. (Barrons.com)
02:27PM	Moderna reaches vaccine settlement, GitLab's guidance disappoints (Yahoo Finance Video)
12:48PM	Iran Diplomacy Hopes, Bitcoin Surge Power Relief Rally: What's Moving Markets Wednesday? (Benzinga)
12:31PM	Stock Market Today: Dow, Nasdaq Higher; Bitcoin Surges On Trump News (Live Coverage) (Investor's Business Daily)
11:35AM	When Fear Hits the Stock Market, Where Can Investors Find Safety? (Barchart)
11:20AM	Loading…
11:20AM	Stock Market Today: Dow Higher Amid Iran, Trump Tariff News; Moderna Soars (Live Coverage) (Investor's Business Daily)
11:19AM	Stocks Rally as US Economic Strength Outweighs Iran War Concerns (Barchart)
10:18AM	Moderna to pay up to $2.25B to settle COVID vaccine patent matter (Proactive)
10:10AM	Moderna Stock Boosted by $2.25 Billion Patent Settlement (The Wall Street Journal)
10:06AM	Moderna will pay up to $2.25B to end COVID vaccine patent fight (Delaware Online \| The News Journal)
09:55AM	MRNA Stock Gains on $2.25B Deal to Settle Patent Dispute With ROIV, ABUS (Zacks)
09:34AM	Stocks to Watch Wednesday: Coinbase, CrowdStrike, Gitlab, Moderna (The Wall Street Journal)
09:01AM	Moderna Pops After Inking $950 Million Covid Vaccine Settlement (Investor's Business Daily)
08:52AM	Moderna shares jump as settlement removes major legal overhang (Investing.com)
08:40AM	Moderna and Ross Stores Lead Stock Gainers on Wednesday (24/7 Wall St.)
08:14AM	Moderna's $950 Million Settlement Clears Legal Overhang, Stock Soars (Benzinga)
08:14AM	Moderna Just Settled a Lawsuit. What It Means for the Stock. (Barrons.com)
06:13AM	Moderna shares pop, and other early market movers (MarketWatch)
06:08AM	These Stocks Are Today's Movers: Moderna, CrowdStrike, GitLab, Coinbase, Strategy, Broadcom, and More (Barrons.com)
05:25AM	Moderna Stock Rallies. This Big Risk Just Got Eliminated. (Barrons.com)
02:55AM	What 3 recent FDA rejections reveal about shifts inside the agency (Pharma Voice)
Mar-03-26 08:49PM	CrowdStrike, Mobix Labs, Micron Technology, Target And Moderna: Why These 5 Stocks Are On Investors' Radars Today (Benzinga) -5.71%
05:30PM	Moderna's stock rallies more than 10% as deal over a patent dispute clears vaccine pipeline (MarketWatch)
04:46PM	Moderna to Pay $950 Million to Settle Patent Cases From Arbutus, Genevant (The Wall Street Journal)
Mar-02-26 07:49AM	MRNA Stock Gains After CHMP Endorses COVID-19-Influenza Combo Shot (Zacks)
Feb-27-26 07:02PM	Analyst Report: Moderna, Inc. (Morningstar Research)
07:23AM	Modernas Covid-Flu Vaccine Recommended for Approval in EU (The Wall Street Journal)
07:00AM	European Medicines Agency's Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Marketing Authorization of mCOMBRIAX, Moderna's mRNA Combination Vaccine Against Influenza and COVID-19 (ACCESSWIRE)
06:45AM	Modernas combination flu, COVID shot wins over European drug regulators (BioPharma Dive)
Feb-25-26 11:08AM	FDA reversal on mRNA-1010 could transform the seasonal influenza vaccines market (Clinical Trials Arena)
Feb-24-26 11:01PM	3 Reasons to Avoid MRNA and 1 Stock to Buy Instead (StockStory)
02:52AM	Will the FDA yank mRNA vaccines? (Pharma Voice)
Feb-23-26 12:50PM	Moderna Stock Is Trading Higher Today: What's Going On? (Benzinga)
Feb-22-26 09:05AM	Moderna, Coinbase, And Global Payments Are Among the Top 10 Large-Cap Gainers Last Week (Feb. 16-Feb. 20): Are the Others in Your Portfolio? (Benzinga)
Feb-20-26 03:24PM	Trump Doubles Down On Tariffs After Supreme Court Blow: The Week On Wall Street (Benzinga)
02:09PM	Geopolitical Tensions Resurface Amid Volatile Week (Schaeffer's Research)
11:02AM	Moderna Faces Lawsuit From BioNTech Over Next-Generation COVID-19 Shot (Benzinga)
12:32AM	Moderna's Q4 Earnings Call: Our Top 5 Analyst Questions (StockStory)
Feb-19-26 10:30AM	Moderna Stock Jumps After FDA Reverses Course on Flu Shot (Zacks) +6.65%
07:00AM	Moderna to Present at Upcoming Conferences in March 2026 (ACCESSWIRE)
06:25AM	Markets Are in the AI Doldrums. Why Trump's Iran Posturing Could Change That. (Barrons.com)
06:15AM	The Moderna Flu-Shot Drama (The Wall Street Journal)
12:01AM	Moderna Spikes After FDAs About-Face on mRNA Flu Vaccine (The Daily Upside)
Feb-18-26 05:21PM	Podcast: Stocks Rise on Chips Momentum (The Wall Street Journal) +6.08%
05:18PM	Moderna Loses 2 Defenses In Patent Fight (GuruFocus.com)
04:25PM	Moderna Jumps Above 20-Day Moving Average on FDA Flu Vaccine Review. Should You Buy MRNA Stock Here? (Barchart)
04:16PM	These Stocks Are Todays Movers: Nvidia, Palantir, Garmin, Global Payments, Palo Alto, Moderna, Caesars, and More (Barrons.com)
03:57PM	Walmart earnings in focus, Caesars stock surges, Moderna FDA review (Yahoo Finance Video)
03:56PM	Why Moderna (MRNA) Stock Is Trading Up Today (StockStory)
02:30PM	Moderna Stock Rises. FDA Will Review Its Seasonal Flu Vaccine After All. (Barrons.com)
01:54PM	Stocks to Watch Wednesday: Sandisk, Moderna, Caesars, Kenvue (The Wall Street Journal)
01:39PM	In reversal, US FDA will review Moderna's flu vaccine application (Reuters Videos)
01:20PM	FDA Makes U-Turn Again On Moderna New Flu Vaccine Review, Stock Soars (Benzinga)
01:08PM	Moderna says FDA to review its flu vaccine after reversing course (CBS News)
01:01PM	FDA to review Modernas flu jab on agency pivot (Pharmaceutical Technology)
11:20AM	Moderna stock surges as FDA reverses course, agrees to review new flu shot (Yahoo Finance)
11:18AM	Modernas investigational flu vaccine moves forward in FDA review (Proactive)
10:22AM	Moderna got the FDA to change its mind and review its flu vaccine after some concessions (MarketWatch)
10:16AM	Moderna Stock Pops as FDA Application Moves Forward (Schaeffer's Research)
09:45AM	Moderna Says FDA Will Review Flu Vaccine, Reversing Earlier Decision. The Stock Is Rising. (Barrons.com)
09:43AM	Berkshire reduces Apple stake, FDA to review Moderna vaccine (Yahoo Finance Video)
09:27AM	Moderna Says FDA Will Review Its Flu Vaccine. The Stock Is Rising. (Barrons.com)
09:12AM	FDA Reverses Course and Will Now Review Moderna's Flu Shot (The Wall Street Journal)
09:04AM	Moderna Jumps After FDA Reverses Decision On Flu Vaccine (Investor's Business Daily)
Feb-17-26 04:33PM	Stocks Recover on Strength in Apple and Airline Stocks (Barchart)
11:22AM	Market Update: Afternoon Gains for Major Indexes (Barchart)
10:42AM	Moderna Stock Rises After EU Marketing Authorization For mNEXSPIKE (Benzinga)
07:00AM	Moderna Receives European Commission Marketing Authorization for COVID-19 Vaccine mNEXSPIKE (ACCESSWIRE)
Feb-16-26 07:48AM	Moderna's Shares Climb 5.3% as Investors Revisit Biotech Leaders (Zacks)
Feb-14-26 12:31AM	MRNA Q4 Deep Dive: New Vaccines, Cost Controls, and Pipeline Milestones Shape Outlook (StockStory)
Feb-13-26 05:29PM	Analyst Report: Moderna, Inc. (Morningstar Research) +5.29%
05:12PM	Stocks to Watch Friday Recap: Applied Materials, Coinbase, DraftKings (The Wall Street Journal)
05:03PM	Health Care Roundup: Market Talk (The Wall Street Journal)
04:51PM	Moderna Is Losing Less Money Than Expected. The Stock Jumps After Earnings. (Barrons.com)
04:20PM	Applied Materials, Rivian, Moderna, Arista, Fastly, Coinbase, Robinhood, DraftKings, and More Stock Market Movers (Barrons.com)

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Klinger Shannon Thyme	Chief Legal Officer	Mar 02 '26	Option Exercise	30.96	13,885	429,880	73,574	Mar 03 04:10 PM
Klinger Shannon Thyme	Chief Legal Officer	Mar 02 '26	Sale	52.29	13,885	726,047	59,689	Mar 03 04:10 PM
Klinger Shannon Thyme	Officer	Mar 02 '26	Proposed Sale	52.29	13,885	726,047		Mar 02 09:56 AM
Hoge Stephen	President	Feb 23 '26	Option Exercise	19.15	160,009	3,064,172	1,617,436	Feb 25 04:49 PM
Hoge Stephen	President	Feb 23 '26	Sale	48.84	160,009	7,814,840	1,457,427	Feb 25 04:49 PM
Hoge Stephen	Officer	Feb 23 '26	Proposed Sale	48.84	160,009	7,814,840		Feb 23 10:26 AM
AFEYAN NOUBAR	Director	Dec 11 '25	Option Exercise	10.90	23,853	259,998	27,777	Dec 15 09:00 AM
AFEYAN NOUBAR	Director	Dec 11 '25	Sale	29.48	23,853	703,306	3,924	Dec 15 09:00 AM
Bancel Stephane	Chief Executive Officer	Dec 11 '25	Option Exercise	10.90	688,073	7,499,996	6,181,970	Dec 15 08:59 AM
Flagship Pioneering Inc.	Affiliate	Dec 11 '25	Proposed Sale	29.49	23,853	703,306		Dec 11 04:30 PM
Hussain Abbas	Director	Dec 09 '25	Sale	27.60	504	13,910	1,515	Dec 11 04:16 PM
Hussain Abbas	Director	Dec 09 '25	Proposed Sale	27.60	504	13,910		Dec 09 10:26 AM
Hussain Abbas	Director	Jun 11 '25	Sale	28.00	312	8,736	580	Jun 12 04:22 PM
Hussain Abbas	Director	Jun 11 '25	Proposed Sale	28.00	312	8,736		Jun 11 10:06 AM

GENB

Generate Biomedicines Inc

MRNA

Moderna Inc

Upgrade your FINVIZ experience